These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22507787)

  • 1. Hematopoietic cell transplantation for chronic myeloid leukemia in developing countries: perspectives from Latin America in the post-tyrosine kinase inhibitor era.
    Pasquini MC
    Hematology; 2012 Apr; 17 Suppl 1():S79-82. PubMed ID: 22507787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of long-term outcomes of donor lymphocyte infusions and tyrosine kinase inhibitors in patients with relapsed CML after allogeneic hematopoietic cell transplantation.
    Shanavas M; Messner HA; Kamel-Reid S; Atenafu EG; Gupta V; Kuruvilla J; Kim DD; Uhm J; Lambie A; Ellis L; Lipton JH
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):87-92. PubMed ID: 24252361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloid leukemia-transplantation in the tyrosine kinase era.
    Innes AJ; Apperley JF
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1037-53. PubMed ID: 25459178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase inhibitors and allogeneic hematopoietic cell transplantation for chronic myeloid leukemia: targeting both therapeutic modalities.
    Fernandez HF; Kharfan-Dabaja MA
    Cancer Control; 2009 Apr; 16(2):153-7. PubMed ID: 19337201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting.
    Faye BF; Dieng N; Seck M; Gadji M; Gueye YB; Sy D; Toure SA; Sall A; Toure AO; Dieye TN; Diop S
    Ann Hematol; 2016 Oct; 95(10):1603-10. PubMed ID: 27370991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
    Nair AP; Barnett MJ; Broady RC; Hogge DE; Song KW; Toze CL; Nantel SH; Power MM; Sutherland HJ; Nevill TJ; Abou Mourad Y; Narayanan S; Gerrie AS; Forrest DL
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1437-44. PubMed ID: 25865648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.
    Wright MP; Shepherd JD; Barnett MJ; Nantel SH; Sutherland HJ; Toze CL; Hogge DE; Nevill TJ; Song KW; Abou Mourad YR; Narayanan S; Power MM; Smith CA; Forrest DL
    Biol Blood Marrow Transplant; 2010 May; 16(5):639-46. PubMed ID: 20005967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic cell transplantation in chronic myeloid leukemia in the age of tyrosine kinase inhibitors.
    Copelan EA; Grunwald MR; Ghosh N; Plesca D; Trivedi J; Avalos BR
    Discov Med; 2015 Mar; 19(104):213-8. PubMed ID: 25828525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of hematopoietic stem cell transplantation in chronic myeloid leukemia.
    Gratwohl A; Baldomero H; Passweg J
    Ann Hematol; 2015 Apr; 94 Suppl 2():S177-86. PubMed ID: 25814084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
    Suttorp M; Yaniv I; Schultz KR
    Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S115-22. PubMed ID: 21195300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors.
    Martin MG; Dipersio JF; Uy GL
    Leuk Lymphoma; 2009 Jan; 50(1):14-23. PubMed ID: 19117213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study.
    Özen M; Üstün C; Öztürk B; Topçuoğlu P; Arat M; Gündüz M; Atilla E; Bolat G; Arslan Ö; Demirer T; Akan H; İlhan O; Beksaç M; Gürman G; Özcan M
    Turk J Haematol; 2017 Mar; 34(1):16-26. PubMed ID: 27094579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives for the treatment of chronic myeloid leukemia.
    Aladağ E; Haznedaroğlu İC
    Turk J Med Sci; 2019 Feb; 49(1):1-10. PubMed ID: 30761815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges for allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
    Oyekunle A; Klyuchnikov E; Ocheni S; Kröger N; Zander AR; Baccarani M; Bacher U
    Acta Haematol; 2011; 126(1):30-9. PubMed ID: 21411987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?
    Ruiz-Argüelles GJ; Tarin-Arzaga LC; Gonzalez-Carrillo ML; Gutierrez-Riveroll KI; Rangel-Malo R; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Gómez-Almaguer D; Giralt S
    Bone Marrow Transplant; 2008 Jul; 42(1):23-8. PubMed ID: 18612313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation.
    Suttorp M; Millot F
    Hematology Am Soc Hematol Educ Program; 2010; 2010():368-76. PubMed ID: 21239821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplant to treatment-free remission: the evolving view of 'cure' in chronic myeloid leukemia.
    Yong AS; Brissot E; Rubinstein S; Savani BN; Mohty M
    Expert Rev Hematol; 2015 Dec; 8(6):785-97. PubMed ID: 26364871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naïve and -exposed Southeast Asian chronic myeloid leukemia patients.
    Wongboonma W; Thongnoppakhun W; Auewarakul CU
    Exp Mol Pathol; 2012 Apr; 92(2):259-65. PubMed ID: 22314255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell transplantation for chronic myeloid leukemia (CML): current indications and perspectives.
    Bacigalupo A
    Curr Cancer Drug Targets; 2013 Sep; 13(7):775-8. PubMed ID: 24041269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic transplantation for CML in the TKI era: striking the right balance.
    Innes AJ; Milojkovic D; Apperley JF
    Nat Rev Clin Oncol; 2016 Feb; 13(2):79-91. PubMed ID: 26573423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.